The agents of non-A, non-B viral hepatitis

[Prevention of perinatal viral hepatitis A, B, and non-A, non-B].

We studied the blood distribution of T and B cells in relation to the etiology and the course of the hepatitis process, in 61 consecutive patients with acute viral hepatitis (AVH). Patients with acute viral hepatitis B showed a significant increase in total T, active T and SmIg cells, lasting the first two weeks of disease. These alterations disappeared in patients with resolving hepatitis. SmI...

Non-A, non-B hepatitis.

Diagnosis of non-A, non-B hepatitis (NANB) is made after exclusion of other known causes of hepatitis. Parenterally spread non-a, non-B hepatitis (PNANB) and enterally transmitted non-A, non-B hepatitis (ENANB) almost certainly appear to be two different diseases. The definite causative agents have not hitherto been identified. Much of our knowledge of NANB is based on (i) experimental studies ...

Non A/non B hepatitis.

The concept that human viral hepatitis was caused by no more than two etiologic agents stemmed from early volunteer studies in which two epidemiologically distinct types of hepatitis were transmitted to humans (1). These experimentally transmitted diseases closely resembled two forms of naturally occurring viral hepatitis that could be distinguished on epidemiologic grounds. One form was highly...

non-A, non-B hepatitis

1 Dodecanissou Street, Athens 12351, Greece. Abstract To assess the safety and possible efficacy of recombinant human interferon alfa-2b in preventing the development of chronic hepatitis, 24 adults (eight men, 16 women) with acute non-A, non-B (NANB) hepatitis were recruited to a pilot study. Half of the cases were parenterally transmitted and half were community acquired. Twelve patients rece...

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs